Breaking News

Emergent Expands Commercial Ops Capabilities

Adds ABEC CSR dual purpose single-use systems for large scale 750L microbial fermentation and 500L mammalian cell culture

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ABEC, a global provider of services for biopharmaceutical manufacturing, announced the shipment of Emergent BioSolutions’ CSR dual purpose single-use systems for large scale 750L microbial fermentation and 500L mammalian cell culture. The dual purpose systems are custom designed to accommodate Emergent’s process needs and operational requirements and complement Emergent’s 4,000L CSR single-use bioreactor capability. ABEC’s CSR dual purpose systems significantly expands Emergent’s commercial o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters